New research in lab models indicates that low doses of carbon monoxide — comparable to that experienced by smokers — protected against neurodegeneration and prevented the accumulation of a key Parkinson’s-associated protein in the brain.

From Stephen Gomperts and colleagues, first author K. N. Rose. Read more at the Harvard Gazette.